Journals
.jpg)
.jpg)
Current IACM-Bulletins
The IACM-Bulletin is a FREE bi-weekly e-mail newsletter, covering news topics on all aspects of Cannabis as medicine. To receive IACM-Bulletin per e-mail, please subscribe online.
[IACM Homepage] [IACM-Bulletin Year 2023] [2022] [2021] [2019] [2018] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
- IACM-Bulletin of 20 December 2020
- IACM: 20 years of IACM: a look back and ahead
- Science/Human: Cannabis may be useful in Parkinson’s disease according to survey
- Science/Human: About one third of cancer patients in Canada use cannabis
- Science/Human: Cannabis use by women with pelvic pain increased after legalisation in Canada
- Science/Human: Cannabis may be effective in the self-management of endometriosis according to a survey
- IACM-Bulletin of 06 December 2020
- UNO: UN drug agency loosens control on cannabis by following the advice of WHO
- Science/Human: Most cancer survivors used cannabis for the treatment of pain and improved sleep according to a survey
- Science/Human: The use of cannabis has beneficial effects among palliative cancer patients according to a survey
- Science/Human: Cannabis may improve chronic pelvic pain in women according to a survey
- Science/Human: Elder adults find cannabis useful in the treatment of several chronic medical conditions according to interviews
- Science/Human: Cannabis may be more effective in the treatment of migraine than standard medication according to survey
- Science/Human: Impaired driving performance after inhaled THC is no longer detectable after 4 hours, while CBD does not impair driving performance according to on-road tests
- Science/Human: Parent and patient perceptions of medical cannabis in the childhood cancer context according to interviews
- European Union: CBD is not a narcotic the highest court of the European Union ruled
- IACM-Bulletin of 08 November 2020
- USA: Arizona, New Jersey South Dakota and Montana legalized the use of cannabis for adults, South Dakota and Mississippi for medical use
- Science/Human: Cannabis reduces pain in patients with fibromyalgia
- Science/Human: Cannabis use does not increase work related injury risk
- Science/Human: Cannabis was helpful in burning mouth syndrome in a pilot study
- IACM-Bulletin of 25 October 2020
- IACM: Free Anniversary Online Meeting on 5 November 2020 to celebrate the 90th birthday of Raphael Mechoulam
- USA: Vermont is the eleventh state to legalise cannabis use by adults
- Science/Human: Improvement of pain by cannabis in large prospective open study
- Science/Human: An inhibitor of endocannabinoid degradation slightly improved symptoms in patients with social anxiety disorder
- Science/Human: The initiation of a cannabis therapy reduced alcohol use in a large that cross-sectional study
- IACM-Bulletin of 11 October 2020
- IACM: Free Webinars and Anniversary Online Meeting between October and December 2020
- Science/Human: The use of cannabis is an emerging treatment for common symptoms in older adults
- Science/Human: More than a quarter of women use cannabis for menopause symptom management
- Science/Human: Cannabis does not have a major impact on cognition in patients treated for chronic pain
- Science/Human: Many cancer patients use cannabis but are often not well informed
- IACM-Bulletin of 27 September 2020
- IACM: Prof. Elisaldo Araújo Carlini, cannabinoid research pioneer, passed away at the age of 90
- Science/Human: Cannabis use may reduce cancer risk according to review
- Science/Human: People living with HIV, who use cannabis, present with better cognitive performance
- Science/Human: A large number of patients with back pain are able to stop opioid use after initiation of cannabis use
- Science/Human: The liberalisation of CBD products resulted in the reduction of other medicinal drugs
- IACM-Bulletin of 13 September 2020
- IACM: Free online events: webinars and anniversary online meeting
- Paraguay: Parliament approves legalisation of cannabis self-cultivation for medicinal use
- Science/Human: Regular cannabis users have no altered pain perception
- Science/Human: Topical cannabis may be helpful in the treatment of leg ulcers according to open trial
- Science/Human: Cannabis may have a positive effect on quality of life in older persons according to a survey
- IACM-Bulletin of 30 August 2020
- Israel: Reduced prices for medical cannabis and CBD no longer a narcotic
- Science/Human: Frequent cannabis use reduces opioid use
- Science/Human: Cannabis use is associated with a reduced risk of diabetes in people with hepatitis C
- Science/Human: Cannabis use reduced hospitalisation of patients with sickle cell disease
- IACM-Bulletin of 16 August 2020
- Thailand: Patients may cultivate their own cannabis for medical use
- Science/Human: THC may be helpful in the treatment of post-traumatic stress disorder
- Science/Human: Cannabis use is associated with reduced viral load in people with HIV who use cocaine
- Science/Human: CBD was effective in the treatment of cannabis use disorders in clinical study
- Science/Human: Cannabis use associated with reduced hospital deaths due to heart failure
- IACM-Bulletin of 02 August 2020
- IACM: Deadline for submission of abstracts extended for the IACM 2020 Virtual Conference on Cannabinoids – Special sponsoring opportunities
- Europe: In a preliminary view the European Commission states that industrial hemp is a narcotic drug
- Science/Human: Cannabis effective in the treatment of migraine
- Argentina: The country allows cannabis sales in pharmacies and home cultivation
- Science/Human: CBD a safe treatment for cannabis use disorders, study finds
- IACM-Bulletin of 19 July 2020
- IACM: Sophisticated possibilities to present posters at the virtual Conference
- Science/Human: In Canada about 20% of patients with arthritis and muscle pain use cannabis and more would like to try it
- Science: CBD and CBG in mouthwash as effective as chlorhexidine
- Science/Human: Cannabis has no negative impact on fitness in older adults
- IACM-Bulletin of 05 July 2020
- Switzerland: Government wants to make cannabis available for medical use
- Science/Human: Inhalation cannabis with a new metered-dose inhaler caused immediate pain relief
- Science/Human: Cannabis use is associated with lower biomarkers for inflammation in patients with HIV
- Science/Human: Cannabis may be helpful in migraine according to small study
- Science/Human: Cannabis may be cause immediate relief in depression and this effect was mainly due to THC
- Science/Human: Cannabis improves pain and quality of life in chronic pain patients according to large observational study
- IACM-Bulletin of 21 June 2020
- IACM: Free access to webinars and other benefits of an IACM membership
- IACM: Call for papers for the IACM virtual Cannabinoid Conference 2020
- Science/Human: Patients, who use cannabis, have a better quality of life
- Science/Human: The use of CBD hemp supplements has a positive effect on HDL cholesterol
- Science/Human: Cannabis may control blood pressure after injury of the spinal cord according to a case report
- Science/Human: Cannabis use may reduce hospital stays in patients with irritable bowel syndrome
- Science/Human: Cannabis use reduces frequency of migraine attacks
- Science/Human: Medicinal Cannabis Effective for Chronic Insomnia in Clinical Trial
- IACM-Bulletin of 07 June 2020
- Science/Israel: Ancient Israelites may have used a cannabis high as part of religious ritual 3000 years ago
- Science/Human: Study finds no evidence for cannabis use to increase risk for stroke
- Science/Human: The available scientific data do not support the assumption that cannabis use may increase occupational injury
- Science/Human: Cannabis use is associated with reduced symptoms in patients with post-traumatic stress disorder
- Science/Human: Cannabis may be helpful in the treatment of fibromyalgia according to an open study
- Science/Human: Cannabis in addition to standard medication further improves motor performance in patients with multiple sclerosis
- IACM-Bulletin of 26 April 2020
- Science/Human: Cannabis alleviates opioid withdrawal symptoms
- Science/Human: Beneficial effects of cannabis on blood brain barrier function in HIV
- Science/Human: Cannabis use is associated with increased testosterone levels in men
- Science/Human: Cannabis access may reduce the demand for opioids in people with pain
- IACM-Bulletin of 29 March 2020
- Expert Opinion: Claims on infeasibility of cannabis with high THC concentrations for medical use are not supported by science
- Science/Human: THC may be helpful in post-traumatic stress disorder
- Science/Human: Exercise in patients with fibromyalgia increases anandamide levels and decreases pain and depression
- Science/Human: Cannabis, ondansetron, and promethazine are perceived as most effective in treatments for nausea according to a survey
- Science/Human: CBD reduces inflammatory reactions in humans
- Science/Human: CBD may be effective in refractory epileptic spasms
- IACM-Bulletin of 15 March 2020
- UNO: Commission on Narcotic Drugs postpones vote on regulation of cannabis
- Science/Human: Cannabis may be helpful in fibromyalgia according to observational study
- Science/Human: CBD may reduce arterial stiffness and improve function of the inner lining of arterie
- Science/Human: Lower doses of CBD were as effective as higher doses in the treatment of epilepsy in patients with Dravet syndrome
- Science/Human: Cannabis does not reduce cognitive function in older adults, but may improve brain health
- Science/Human: Cannabis improved symptoms in cancer patients despite reduced opioid dose
- IACM-Bulletin of 16 February 2020
- IACM: Conferences in November 2020 in Mexico City and in October 2021 in Basel
- Science/Human: An increasing number of patients with rheumatic diseases in the USA use cannabis
- Science/Human: Cessation of CBD use does not cause withdrawal symptoms
- Science/Human: After passage of medical cannabis laws in the USA workers compensation claiming was reduced
- Science/Human: Cannabis use on is associated with reduced symptoms in ADHD
- IACM-Bulletin of 02 February 2020
- Science/Animal: Cannabigerol effective against infections with antibiotic-resistant bacteria
- Economy/Ecology: Data on how much electricity the cannabis industry consumes
- Science/Human: About half of patients with low back pain were able to stop all opioid use after imitating cannabis use
- Europe/UNO: European Commission proposes unified EU vote on WHO cannabis scheduling
- Science/Human: Many patients with arthritis use cannabis
- Science/Human: Cannabis may be helpful in insomnia in older adults with chronic pain, but tolerance may develop
- IACM-Bulletin of 19 January 2020
- IACM: IACM on Facebook and LinkedIn
- Science/Human: CBD reduces stress in people with a high risk for psychosis
- Science/Human: Tobacco use but not cannabis use during pregnancy was associated with reduced birth weight
- Science/Human: CBD may be helpful in reducing seizures in refractory epilepsy
- Science/Human: CBD was reported to reduce pain and concomitant mood disorder in a patient with neurofibromatosis
- IACM-Bulletin of 05 January 2020
- Italy: Growing small amounts of cannabis at home is not a crime, the High Court rules
- Science/Human: The oral intake together with fat may increase the systemic bioavailability of THC by two-fold
- Science/Human: Exercise reduced headache attacks and anandamide levels in migraine sufferers in controlled study
- Science/Human: Patients with Tourette syndrome prefer medicinal cannabis over pure THC and Sativex according to a survey
[IACM Homepage] [IACM-Bulletin Year 2023] [2022] [2021] [2019] [2018] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000]
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.